Clinical Trial Results:
A Phase 2, proof of concept and dose finding study, investigating treatment efficacy of LEO 29102 cream (2.5 mg/g, 1.0 mg/g, 0.3 mg/g, 0.1 mg/g, 0.03 mg/g), LEO 29102 cream vehicle, and Elidel (Pimecrolimus) cream 10 mg/g, after cutaneous administration twice daily for 4 weeks.
An international, multi-centre, prospective, randomised, double-blind, 7 arm, vehicle-controlled, parallel group study
Summary
|
|
EudraCT number |
2009-013792-22 |
Trial protocol |
DE FI |
Global completion date |
06 Jul 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
18 Dec 2016
|
First version publication date |
18 Dec 2016
|
Other versions |
|
Summary report(s) |
LEO 29102-C21 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.